Levy Howard 4
4 · CATALYST BIOSCIENCES, INC. · Filed Feb 22, 2021
Insider Transaction Report
Form 4
Levy Howard
Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-02-09$4.81/sh+1,670$8,033→ 23,390 total(indirect: By Trust)
Footnotes (1)
- [F1]Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2021.